» Articles » PMID: 36790563

An Electrochemical Immunosensor Based on Polyaniline Microtubules and Zinc Gallinate for Detection of Human Growth Differentiation Factor-15

Overview
Journal Mikrochim Acta
Specialties Biotechnology
Chemistry
Date 2023 Feb 15
PMID 36790563
Authors
Affiliations
Soon will be listed here.
Abstract

The incidence rate of cardiovascular diseases (CVDs) remains high, and their mortality rate is significantly higher than that of other diseases. Growth differentiation factor-15 (GDF-15) is a recently developed biomarker for the early diagnosis and prognostic evaluation of CVDs because its concentration in serum increases substantially after a cardiovascular injury or an inflammatory reaction. In this study, a sandwich-type immunosensor was constructed for the sensitive detection of GDF-15. Specifically, peony-like zinc gallinate (ZnGaO) prepared using a hydrothermal method, which exhibits excellent electrocatalytic performance, was coupled with Au nanoparticles (NPs) to obtain golden-peony-like ZnGaO/Au NPs. They preserved the immune activity of GDF-15 antibody molecules and further enhanced the conductivity, thereby realizing additional signal amplification. Hollow polyaniline (PANI) microtubules decorated with Pd NPs were used as the sensing platform (PANI/Pd NPs). The hollow microtubules provided abundant active sites and considerably improved the electron-transfer rate. Under optimal conditions, a linear range and remarkably low detection limit of 100 fg mL-10 ng mL and 42.23 fg mL, respectively, were achieved. These experimental results indicate that the strategy reported herein can be adopted as a novel approach for the convenient and rapid detection of GDF-15.

Citing Articles

Au/PANI@PtCu-based electrochemical immunosensor for ultrasensitive determination of pro-gastrin-releasing peptide.

Fu X, Gao K, Liu N, Guo B, He M, Lai N Mikrochim Acta. 2024; 191(3):126.

PMID: 38332145 DOI: 10.1007/s00604-023-06168-1.


Sandwich-type electrochemical immunosensor based on CuFeO-Pd for cardiac troponin I detection.

Meng Y, Li Y, Liu S, Wang S, Dong H, Jiang F Mikrochim Acta. 2023; 190(6):249.

PMID: 37266715 DOI: 10.1007/s00604-023-05831-x.

References
1.
Chapman N, Thomas E, Tan J, Inglis S, Wu J, Climie R . A roadmap of strategies to support cardiovascular researchers: from policy to practice. Nat Rev Cardiol. 2022; 19(11):765-777. DOI: 10.1038/s41569-022-00700-1. View

2.
Roth G, Mensah G, Johnson C, Addolorato G, Ammirati E, Baddour L . Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25):2982-3021. PMC: 7755038. DOI: 10.1016/j.jacc.2020.11.010. View

3.
Hansen E, Hindberg K, Latysheva N, Aukrust P, Ueland T, Hansen J . Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism. Blood. 2020; 136(16):1863-1870. DOI: 10.1182/blood.2019004572. View

4.
May B, Pimentel M, Zimerman L, Rohde L . GDF-15 as a Biomarker in Cardiovascular Disease. Arq Bras Cardiol. 2021; 116(3):494-500. PMC: 8159541. DOI: 10.36660/abc.20200426. View

5.
Myhre P, Prebensen C, Strand H, Roysland R, Jonassen C, Rangberg A . Growth Differentiation Factor 15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized With COVID-19. Circulation. 2020; 142(22):2128-2137. PMC: 7688084. DOI: 10.1161/CIRCULATIONAHA.120.050360. View